CYSL | Members

Nat Rev Gastroenterol Hepatol

The International Chinese Young Scholars Alliance for the Study of the Liver: facilitating global collaboration

Li W, Cao Z, Yeo YH, et al.

Lancet Gastroenterol Hepatol

Prevalence of liver fibrosis and steatotic liver disease in community-dwelling adults in China (the CHESS-LiverHealth project): cross-sectional baseline data from a prospective cohort study

Liu S, Liu X, Song J, et al.

Gut

Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetes

Chen Y, Dong B, Jin X, et al.

Nature Communications

Unbiased Clustering of Acute-on-Chronic Liver Failure Patients Using Machine Learning in a Real-World ICU Cohort

Zhang M, Ji F, Zu J, et al.

Journal of Hepatology

Blood markers for type-1, -2, and -3 inflammation are associated with severity of acutely decompensated cirrhosis

Cao Z, Yao Y, Cai M, et al.

Lancet Gastroenterol Hepatol

Current and emerging therapeutic landscape for metabolic dysfunction-associated steatohepatitis

Li W, Alazawi W, Loomba R

Gut

Vasomics of the Liver

Wang C, Felli E, Fallowfield JA, et al.

Hepatology

Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction-associated steatotic liver disease

Shang Y, Akbari C, Dodd M, et al.

Lancet Gastroenterol Hepatol

Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium

Cao Z, Wong F, Choudhury AK, et al.

Hepatology

Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease

Qi X, Li J, Caussy C, et al.

Lancet Gastroenterol Hepatol

Natural history and progression of metabolic dysfunction-associated steatotic liver disease

Hagström H, Shang Y, Hegmar H, et al.

Diabetes Care

Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes

Shang Y, Grip ET, Modica A, et al.

Nat Rev Gastroenterol Hepatol

Current and emerging strategies for the prevention of hepatocellular carcinoma

Yeo YH, Abdelmalek M, Khan S, et al.

Gastroenterology

Increased risk of aspiration pneumonia associated with endoscopic procedures among patients with Glucagon-like peptide-1 receptor agonist use

Yeo YH, Gaddam S, Ng WH, et al.

Liver Cancer

The impact of radiation dose and tumour burden on outcomes in hepatocellular carcinoma: 11-year experience in a 413-patient cohort treated with yttrium-90 resin microsphere radioembolisation

Chen K., Aaron KT Tong, et al.

N Engl J Med

VV116 versus Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19

Cao Z, Gao W, Bao H, et al.

Steering Committee

Guiding the strategic direction and scientific vision of CYSL

Zhujun Cao

Ruijin Hospital, Shanghai, China

Decompensated cirrhosis, ACLF and infectious diseases

Kaina Chen

Singapore General Hospital, Singapore

Liver cancer, cirrhosis, portal hypertension, GI endoscopy

Wenhao Li

Secretary‑General

Blizard Institute, Queen Mary University of London, London, UK

Innate immune signaling, T cell immune landscape

Xiaolong Qi

Chair of Steering Committee

Zhongda Hospital, Nanjing, China

Liver Fibrosis, MASLD, Cirrhosis, Portal Hypertension, Screening, Diagnosis, Management

Ying Shang

Karolinska Institutet, Stockholm, Sweden

Steatotic liver disease, MASLD, clinical epidemiology

Yee Hui Yeo

Cleveland Clinic, Cleveland, USA

Alcohol-associated liver disease, AI in Hepatology

Listed in alphabetical order by surname.

Members

A global network of liver disease researchers and clinicians

Listed in alphabetical order by surname.

Mengyao Hu

Zhujiang Hospital, Southern Medical University, Guangzhou, China

Gut microbiota, microbial metabolites & liver diseases

Zhao Huang

Tongji Hospital, China

Refractory HCC & Precision Treatment

Hui Li

Zhongshan Hospital, China

Immunotherapy Resistance in HCC

Chunyan Liu

Nanjing University, China

Liver Regeneration & Tissue Engineering

Haiyuan Shen

Anhui Medical University, China

Metabolic Liver Disease & Gut-liver Axis

Jinwen Song

Fifth Medical Center of Chinese PLA General Hospital, Beijing, China

Immune Pathogenesis Mechanisms of Infectious Diseases

Lintao Wang

Ocean University of China, Qingdao, China

Organ Makeover — regenerative medicine & organ regeneration

Meng Xu

Nanfang Hospital, China

Liver Fibrosis & MAFLD

Tao Zhou

Naval Medical University, China

Single-cell Spatiotemporal Evolution

Our Global Community

CYSL Publications

The International Chinese Young Scholars Alliance for the Study of the Liver: facilitating global collaboration

Prevalence of liver fibrosis and steatotic liver disease in community-dwelling adults in China (the CHESS-LiverHealth project): cross-sectional baseline data from a prospective cohort study

Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetes

Unbiased Clustering of Acute-on-Chronic Liver Failure Patients Using Machine Learning in a Real-World ICU Cohort

Blood markers for type-1, -2, and -3 inflammation are associated with severity of acutely decompensated cirrhosis

Current and emerging therapeutic landscape for metabolic dysfunction-associated steatohepatitis

Vasomics of the Liver

Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction-associated steatotic liver disease

Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium

Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease

Natural history and progression of metabolic dysfunction-associated steatotic liver disease

Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes

Current and emerging strategies for the prevention of hepatocellular carcinoma

Increased risk of aspiration pneumonia associated with endoscopic procedures among patients with Glucagon-like peptide-1 receptor agonist use

The impact of radiation dose and tumour burden on outcomes in hepatocellular carcinoma: 11-year experience in a 413-patient cohort treated with yttrium-90 resin microsphere radioembolisation

VV116 versus Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19

Steering Committee

Zhujun Cao

Kaina Chen

Wenhao Li

Xiaolong Qi

Ying Shang

Yee Hui Yeo

Members

Mengyao Hu

Zhao Huang

Hui Li

Chunyan Liu

Haiyuan Shen

Jinwen Song

Lintao Wang

Meng Xu

Tao Zhou